AU4712796A - A method for the in vitro measurement of the elimination of labelled hcg in humans, an agent to be used in the method as well as the use thereof for the establishment of the elimination of patho-physiologically produced hcg or for the establishment of organ function - Google Patents

A method for the in vitro measurement of the elimination of labelled hcg in humans, an agent to be used in the method as well as the use thereof for the establishment of the elimination of patho-physiologically produced hcg or for the establishment of organ function

Info

Publication number
AU4712796A
AU4712796A AU47127/96A AU4712796A AU4712796A AU 4712796 A AU4712796 A AU 4712796A AU 47127/96 A AU47127/96 A AU 47127/96A AU 4712796 A AU4712796 A AU 4712796A AU 4712796 A AU4712796 A AU 4712796A
Authority
AU
Australia
Prior art keywords
establishment
elimination
hcg
patho
humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47127/96A
Inventor
Thomas Broe Christensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4712796A publication Critical patent/AU4712796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU47127/96A 1995-02-15 1996-02-14 A method for the in vitro measurement of the elimination of labelled hcg in humans, an agent to be used in the method as well as the use thereof for the establishment of the elimination of patho-physiologically produced hcg or for the establishment of organ function Abandoned AU4712796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK16995A DK171745B1 (en) 1995-02-15 1995-02-15 Method for determining the elimination of labeled hCG in humans, agent for use in the method, and its use for determining pathophysiologically formed hCG elimination or for determining organ function
DK169/95 1995-02-15
PCT/DK1996/000070 WO1996025180A1 (en) 1995-02-15 1996-02-14 A METHOD FOR THE IN VITRO MEASUREMENT OF THE ELIMINATION OF LABELLED hCG IN HUMANS, AN AGENT TO BE USED IN THE METHOD AS WELL AS THE USE THEREOF FOR THE ESTABLISHMENT OF THE ELIMINATION OF PATHO-PHYSIOLOGICALLY PRODUCED hCG OR FOR THE ESTABLISHMENT OF ORGAN FUNCTION

Publications (1)

Publication Number Publication Date
AU4712796A true AU4712796A (en) 1996-09-04

Family

ID=8090555

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47127/96A Abandoned AU4712796A (en) 1995-02-15 1996-02-14 A method for the in vitro measurement of the elimination of labelled hcg in humans, an agent to be used in the method as well as the use thereof for the establishment of the elimination of patho-physiologically produced hcg or for the establishment of organ function

Country Status (4)

Country Link
EP (1) EP0809518A1 (en)
AU (1) AU4712796A (en)
DK (1) DK171745B1 (en)
WO (1) WO1996025180A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874693A (en) * 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction

Also Published As

Publication number Publication date
DK16995A (en) 1996-08-16
EP0809518A1 (en) 1997-12-03
DK171745B1 (en) 1997-04-28
WO1996025180A1 (en) 1996-08-22

Similar Documents

Publication Publication Date Title
AU3477899A (en) Device and method to slow or stop the heart temporarily
AUPN720295A0 (en) Apparatus for attaching objects to walls and the like
AU7837898A (en) Method for measuring myocardial motion and the like
AU6381899A (en) Method of producing superplastic alloys and superplastic alloys produced by the method
AU3986795A (en) Succinic acid derivatives and their use as surfactants
AU7697091A (en) Pressure-sensitive, adhesive-backed substrates and method for producing same
AU1943699A (en) Patterned coated articles and methods for producing the same
AU4111597A (en) Method for increasing the significance of tridimensional measuring of objects
TR199600792A2 (en) Process for the preparation of dihaloazolopyrimidines.
AU3684895A (en) Use of human chorionic gonadotropin as an immune-potentiating agent
AU5779400A (en) Process for the preparation of 3,3-dimethylbutanal
AU2660900A (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents
AU1467395A (en) Compound cell structure and method for producing the same
AU1036499A (en) Method and device for the production of pure water
CA2302224A1 (en) Fibrinogen-based tissue adhesive
AU6821796A (en) Contraceptive combined preparation, kits containing the same and contraceptive method using this combined preparation
AU1607299A (en) Substituted amidinoaryl derivatives and their use as anticoagulants
CA2216583A1 (en) Levobupivacaine and its use as an anaesthetic in pregnant women
AU6017396A (en) Prostaglandins and process for producing the same
AU1895395A (en) Method for measuring loads being directed to structures
AU1983499A (en) Solar cell device and method of producing the same
AU1608399A (en) Substituted amidinoaryl derivatives and their use as anticoagulants
KR970006271A (en) Pyrocarboxylic acid diesters and methods for producing the same
AU1220599A (en) Method for the production and use of dendritic cells
AU2002237253A1 (en) Biosensor and method of producing the same